Secukinumab is effective in treatment of moderate-to-severe plaque psoriasis: Real-life effectiveness and safety from the PROSPECT study
Journal of the European Academy of Dermatology and Venereology | Oct 25, 2019
Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis
Journal of the American Academy of Dermatology | Oct 24, 2019
Prognostic factors in patients with primary cutaneous anaplastic large cell lymphoma. A multicentric, retrospective analysis of the Spanish Group of Cutaneous Lymphoma
Journal of the European Academy of Dermatology and Venereology | Oct 24, 2019
Most read this week